drugset / Trial / NCT03682172

Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects

NCT03682172

Phase 0 Completed 15 enrolled Steno Diabetes Center Copenhagen
RandomizedParallel-groupDouble-blindBasic science

Summary

The study will investigate the effect of the incretin hormone glucagon-like peptide 2 (GLP-2) on postprandial gallbladder motility in young, healthy, male subjects. The study is double-blinded, randomized and placebo controlled. 15 subjects will be included. On three separate study days (A, B, C) the subjects will receive an four hour intravenous infusion with either saline (placebo), GLP-2 at a rate of 1 pmol/kg/min or GLP-2 at a rate of 10 pmol/kg/min 30 minutes after the infusion start the subject will receive a liquid meal which will stimulate gallbladder contraction. The gallbladder volume will be determined by frequent ultrasonic scans, and blood samples will be drawn on fixed times through out the study day.

Timeline

Start
2018-05-01
Primary completion
2018-08-30
Completion
2020-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject GLUCAGON-LIKE PEPTIDE II Peptide 1 unknown Intravenous
Subject GLUCAGON-LIKE PEPTIDE II Peptide 10 unknown Intravenous

Indications